共 50 条
Head-to-Head Comparison of 68Ga-DOTA-TATE and 68Ga-DOTA-JR11 PET/CT in Patients With Tumor-Induced Osteomalacia: A Prospective Study
被引:6
|作者:
Hou, Guozhu
[1
,2
]
Zhang, Yuwei
[1
,2
]
Liu, Yu
[1
,2
]
Wang, Peipei
[1
,2
]
Xia, Weibo
[3
]
Xing, Xiaoping
[3
]
Huo, Li
[1
,2
]
Li, Fang
[1
,2
]
Jing, Hongli
[1
,2
]
机构:
[1] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Nucl Med, State Key Lab Complex Severe & Rare Dis, Beijing, Peoples R China
[2] Beijing Key Lab Mol Targeted Diag & Therapy Nucl, Beijing, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Endocrinol, State Key Lab Complex Severe & Rare Dis, Beijing, Peoples R China
来源:
关键词:
Ga-68-DOTA-TATE;
Ga-68-DOTA-JR11;
TIO;
causative tumor;
multiple;
DOTATATE PET/CT;
LOCALIZATION;
PERFORMANCE;
ANTAGONISTS;
F-18-FDG;
D O I:
10.3389/fonc.2022.811209
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
BackgroundThe purpose of this study is to compare the sensitivity of Ga-68-DOTA-JR11 and Ga-68-DOTA-TATE PET/CT for detecting the responsible tumor of tumor-induced osteomalacia (TIO) and investigate if Ga-68-DOTA-JR11 PET/CT can identify the culprit tumor of TIO in multiple suspicious lesions in Ga-68-DOTA-TATE PET/CT. MethodsA total of 19 patients with suspected TIO were prospectively recruited in this study. Each patient underwent whole-body PET/CT scan 40-60 min postinjection using Ga-68-DOTA-TATE and Ga-68-DOTA-JR11 on the same PET/CT, respectively in sequence, and on consecutive days. The diagnosis of TIO was confirmed by the combination of the postsurgical pathological results of the tumor and clinical information. ResultsAmong the 19 patients with TIO who were included in this study, culprit tumors from all patients were confirmed pathologically. Ga-68-DOTA-TATE PET/CT positively identified the causative tumor in 18/19 patients, whereas Ga-68-DOTA-JR11 PET/CT was positive in 11/19 patients (94.7% vs. 57.9%, respectively; p < 0.05). Ga-68-DOTA-TATE PET/CT demonstrated more than one increased focal activity in 7 patients for a total of 16 lesions (3 lesions each in 2 patients and 2 lesions each in the rest 5 patients). However, seven of these 16 lesions showed concordant results on Ga-68-DOTA-JR11 PET/CT by demonstrating increased activity (one lesion in each of the 7 patients). The surgical specimens of the lesions in these 7 patients confirmed the phosphaturic mesenchymal tumor. A total of 11 culprit tumors were positive in both Ga-68-DOTA-TATE and Ga-68-DOTA-JR11 PET/CT. The SUVmax of 11 culprit tumors was significantly higher on Ga-68-DOTA-TATE PET/CT compared with that on Ga-68-DOTA-JR11 PET/CT (17.8 +/- 12.5 vs. 6.8 +/- 6.2; p < 0.05). Conclusions(68)Ga-DOTA-TATE PET/CT is more sensitive to Ga-68-DOTA-JR11 PET/CT in the detection of the culprit tumor of TIO. However, Ga-68-DOTA-JR11 PET/CT might be helpful to identify the tumor in multiple suspicious lesions in Ga-68-DOTA-TATE PET/CT.
引用
收藏
页数:6
相关论文